Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment

NCT04530422 is registered in ClinicalTrials.gov with Almaza Military Fever Hospital as lead sponsor.

NCT NCT04530422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment
Lead sponsor
Almaza Military Fever Hospital
Phase
Phase 3
Overall status
Completed
Start date
April 15, 2020
Completion date
July 23, 2020
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19